← All stocks

Cellectar Biosciences, Inc.

CLRB Net buying
CIK 0001279704 #4979 in the set updated 20 Sep 2026
Bought (12 mo)
$50.00K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$731.99
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$731.99
1 of 1 sales
Net
+$49.26K
+$49.26K against sales at will

By person

4 insiders · 3 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
CARUSO JAMES V
President & CEO
$25.00K (1)
+$25.00K
20,318
$58.52K
+1,140%
Longcor Jarrod
Chief Operating Officer
$25.00K (1)
+$25.00K
20,451
$58.90K
NEIS JOHN
Director
$731.99 (1)
−$731.99
10
$28.80
−95.2%
Kolean Chad J
CFO
6,418
$18.48K
+352.6%

No percentages here. This company's share count has moved by a factor of 14.4 over the window, from 3,192,040 to 46,079,875 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
NEIS JOHN
12 Dec 2025
Director
Sell indirect
198
$3.70
$731.99

What was left out

Form 4 filings counted 12
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 0
History held since 1 Nov 2016